文献リスト

1) Zhao X, Alvarado D, Rainier S, et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet. 2001; 29: 326-31

2) Hazan J, Fonknechten N, Mavel D, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 1999; 23: 296-303

3) Rainier S, Chai J-H, Tokarz D, et al. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet. 2003; 73: 967-71

4) Valdmanis PN, Meijer IA, Reynolds A, et al. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet. 2007; 80: 152-61

5) Seri M, Cusano R, Forabosco P, et al. Genetic mapping to 10q23. 3-q24. 2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet. 1999; 64: 586-93

6) Reid E, Kloos M, Ashley-Koch A, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002; 71: 1189-94

7) Reid E, Dearlove AM, Osborn O, et al. A locus for autosomal dominant 'pure' hereditary spastic paraplegia maps to chromosome 19q13. Am J Hum Genet. 2000; 66: 728-32

8) Hansen JJ, Durr A, Cournu-Rebeix I, et al. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet. 2002; 70: 1328-32

9) Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet. 2004; 36: 271-6

10) Valente EM, Brancati F, Caputo V, et al. Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33-q34. Ann Neurol. 2002; 51: 681-5

11) Orlacchio, A, Kawarai T, Gaudiello F, et al. New locus for hereditary spastic paraplegia maps to chromosome 1p31. 1-1p21. 1. Ann Neurol. 2005; 58: 423-9

12) Zuchner S, Wang G, Tran-Viet K-N, et al. Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet. 2006; 79: 365-9

13) Mannan AU, Krawen P, Sauter SM, et al. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet. 2006; 79: 351-7

14) Ashley-Koch A, Bonner ER, Gaskell PC, et al. Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia. Neurogenetics. 2001; 3: 91-7

15) Hentati A, Pericak-Vance MA, Hung W-Y, et al. Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet. 1994; 3: 1263-7

16) Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973- 83

17) Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007; 39: 366-72

18) Vazza G, Zortea M, Boaretto F, et al. A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. Am J Hum Genet. 2000; 67: 504-9

19) Hughes CA, Byrne PC, Webb S, et al. SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q. Neurology 2001; 56: 1230-3

20) Patel H, Cross H, Proukakis C, et al. SPG20 is mutated in Troyer syndrome, a hereditary spastic paraplegia. Nature Genet. 2002; 31: 347-8

21) Simpson MA, Cross H, Proukakis C, et al. Maspardin is mutated in Mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet. 2003; 73: 1147-56

22) Blumen SC, Bevan S, Abu-Mouch S, et al. A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32. Ann Neurol. 2003; 54: 796-803

23) Hodgkinson CA, Bohlega S, Abu-Amero SN, et al. A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14. Neurology 2002; 59: 1905-9

24) Zortea M, Vettori A, Trevisan CP, et al. Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23. 3-q24. 1. J Med Genet. 2002; 39: 387-90

25) Wilkinson PA, Simpson MA, Bastaki L, et al. A new locus for autosomal recessive complicated hereditary spastic paraplegia (SPG26) maps to chromosome 12p11. 1-12q14. J Med Genet. 2005; 42: 80-2

26) Meijer IA, Cossette P, Roussel J, et al. A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22. 1-10q24. 1. Ann Neurol. 2004; 56: 579-82

27) Bouslam N, Benomar A, Azzedine H, et al. Mapping of a new form of pure autosomal recessive spastic paraplegia (SPG28). Ann Neurol. 2005; 57: 567-71

28) Klebe S, Azzedine H, Durr A, et al. Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37. 3. Brain. 2006; 129: 1456- 62

29) Stevanin G, Paternotte C, Coutinho P, et al. A new locus for autosomal recessive spastic paraplegia (SPG32) on chromosome 14q12-q21. Neurology. 2007; 68: 1837-40

30) Eymard-Pierre E, Lesca G, Dollet S, et al. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002; 71: 518-27

31) Macedo-Souza LI, Kok F, Santos S, et al. Spastic paraplegia, optic atrophy, and neuropathy is linked to chromosome 11q13. Ann Neurol. 2005; 57: 730-7

32) Lynex CN, Carr IM, Leek JP, et al. Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with stiff-person syndrome and other movement disorders. BMC Neurol. 2004; 4: 20 (Electronic Article)

33) Engert JC, Berube P, Mercier J, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11. 5-kb ORF. Nat Genet. 2000; 24: 120-5

34) Jouet M, Rosenthal A, Armstrong G, et al. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nature Genet. 1994; 7: 402-7

35) Saugier-Veber P, Munnich A, Bonneau D, et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet. 1994; 6: 257-62

36) Steinmuller R, Lantigua-Cruz A, Garcia-Garcia R, et al. Evidence of a third locus in X-linked recessive spastic paraplegia. Hum Genet. 1997; 100: 287-9

37) Wells CR, Jankovic J. Familial spastic paraparesis and deafness: a new X-linked neurodegenerative disorder. Arch Neurol. 1986; 43: 943-6

38) Durr A, Camuzat A, Colin E, et al. Atlastin 1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol. 2004; 61: 1867-72

39) Namekawa M, Ribai P, Nelson I, et al. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology. 2006; 66: 112-4

40) Sauter SM, Engel W, Neumann LM, et al. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus. Hum Mutat. 2004; 23: 98

41) Ivanova N, Claeys KG, Deconinck T, et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol. 2007; 64: 706-13

42) Tessa A, Casari C, damiano M, et al. SPG3A: an additional family carrying a new atlastin mutation. Neurology. 2002; 59: 2002-5

43) Meijer IA, Dion P, Laurent S, et al. Characterization of a novel SPG3A deletion in a French-Canadian family. Ann Neurol. 2007; 61: 599-603

44) Rainier S, Sher C, Reith O, et al. De novo occurrence of novel SPG3A/Atlastin mutation presenting as cerebral palsy. Arch Neurol. 2006; 63: 445-7

45) Matsui M, Kawarai T, Hase Y, et al. A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia. J Neurol. 2007; 254: 972-4

46) Li XH, Song C, Chen SQ, et al. A SPG3A mutation with a novel foot phenotype of hereditary spastic paraplegia in a Chinese Han family. Chin Med J. 2007; 120: 834-7

47) Zhu PP, Patterson A, Lavoie B, et al. Cellular localization, oligomerization, and membrane association of the hereditary spastic paraplegia 3A (SPG3A) protein atlastin. J Biol Chem. 2003; 278: 49063-71

48) Namekawa M, Muriel M-P, Janer A, et al. Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci. 2007; 35: 1-13

49) Fonknechten N, Mavel D, Byrne P, et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet. 2000; 9: 637-44

50) McMonagle P, Byrne PC, Fitzgerald B, et al. Phenotype of AD-HSP due to mutations in the SPAST gene: comparison with AD-HSP without mutations. Neurology. 2000; 55: 1794-800

51) White KD, Ince PG, Lusher M, et al. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology. 2000; 55: 89-94

52) McDermott CJ, Burness CE, Kirby J, et al. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology. 2006; 67: 45-51

53) Meyer T, Schwan A, Dullinger JS, et al. Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology. 2005; 65: 141-3

54) Brugman F, Wokke JHJ, Scheffer H, et al. Spastin mutations in sporadic adult-onset upper motor neuron syndromes. Ann Neurol. 2005; 58: 865-9

55) Namekawa M, Takiyama Y, Sakoe K, et al. A large Japanese SPG4 family with a novel insertion mutation of the SPG4 gene: a clinical and genetic study. J Neurol Sci. 2001; 185: 63-8

56) Yabe I, Sasaki H, Tashiro K, et al. Spastin gene mutation in Japanese with hereditary spastic paraplegia. J Med Genet. 2002; 39: e46

57) Namekawa M, Takiyama Y, Sakoe K, et al. A Japanese SPG4 family with a novel missense mutation of the SPG4 gene: intrafamilial valiability in age at onset and clinical severity. Acta Neurol Scand. 2002; 106: 387-91

58) Depienne C, Tallaksen C, Lephay JY, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006; 43: 259-65

59) Iwanaga H, Tsujino A, Shirabe S, et al. Large deletion involving the 5'-UTR in the spastin gene caused mild phenotype of autosomal dominant hereditary spastic paraplegia. Am J Med Genet. 2005; 133A: 13-7

60) Beetz C, Nygren AOH, Schickel J, et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology. 2006; 67: 1926-30

61) Chinnery PF, Keers SM, Holden MJ, et al. Infantile hereditary spastic paraparesis due to codominant mutations in the spastin gene. Neurology. 2004; 63: 710-2

62) Svenson IK, Kloos MT, Gaskell PC, et al. Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics. 2004; 5: 157-64

63) Erico A, Ballabio A, Rugarli EI. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet. 2002; 11: 153-63

64) 瀧山嘉久, 迫江公己, 嶋崎晴雄, 他. Spastin蛋白の機能解析. 厚生労働省 難病性疾患克服研究事業, 運動失調に関する調査及び病態機序に関する研究班, 平成18年度研究報告書. 2007. p. 95-7

65) Svenson IK, Ashley-Koch AE, Gaskell PC, et al. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet. 2001; 68: 1077-85

66) Patrono C, Casali C, Tessa A, et al. Missense and splice site mutations in SPG4 suggest loss-of-function in dominant spastic paraplegia. J Neurol. 2002; 249: 200-5

67) Sherwood NT, Sun Q, Xue M, et al. Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. PloS Biol. 2004; 2: e429

68) Trotta N, Orso G, Rosseto MG, et al. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol. 2004; 14: 1135- 47

69) Sanderson CM, Connell JW, Edwards TL, et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum Mol Genet. 2006; 15: 307-18

70) Mannan AU, Krawen P, Sauter SM, et al. ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet. 2006; 79: 351-7

71) Mannan AU, Boehm J, Sauter SM, et al. Spastin, the most commonly mutated in hereditary spastic paraplegia interacts with reticulon 1 an endoplasmic reticulum protein. Neurogenetics. 2006; 7: 93-103

72) 岩淵 潔, 本多義明, 日野英忠, 他. 菲薄した脳梁 (低形成) を伴う複合型遺伝性痙性対麻痺の臨床的特徴とその位置づけに関する研究. 神経進歩. 1995; 39: 530-40

73) 岩淵 潔, 久保田裕, 埴原秋児, 他. 脳梁の低形成を伴う複合型遺伝性痙性対麻痺の3例. 脳神経. 1994; 46: 941-7

74) Nakamura A, Izumi K, Umehara F, et al. Familial spastic paraplegia with mental impairment and thin corpus callosum. J Neurol Sci. 1995; 131: 35-42

75) 田中正美, 小林義昭, 佐藤正久, 他. 白内障と脳梁の低形成を伴う複合型遺伝性痙性対麻痺の1例. 臨床神経. 1995; 35: 798-802

76) Martinez Murillo F, Kobayashi H, Pegoraro E, et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology. 1999; 13: 50-6

77) Shibasaki Y, Tanaka H, Iwabuchi K, et al. Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13-15. Ann Neurol. 2000; 48: 108-12

78) Casali C, Valente EM, Bertini E, et al. Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology. 2004; 62: 262-8

79) Lossos A, Stevanin G, Meiner V, et al. Hereditary spastic paraplegia with thin corpus callosum: reduction of the SPG11 interval and evidence for further genetic heterogeneity. Arch Neurol. 2006; 63: 756-60

80) Howard HC, Mount DB, Rochefort D, et al. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet. 2002; 32: 384-92

81) Winner B, Uyanik G, Gross C, et al. Clinical progression and genetic analysisin hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol. 2004; 61: 117-21

82) Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007; 39: 366-72

83) Nagase T, Nakayama M, Nakajima D, et al. Prediction of the coding sequences of unidentified human genes, XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 2001; 8: 85- 95

84) Bouchard JP, Barbeau A, Bouchard R, et al. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Can J Neurol Sci. 1978; 5: 61-9

85) Bouchard JP, Richter A, Mathieu J, et al. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuromuscul Disord. 1998; 8: 474-9

86) Engert JC, Berube P, Mercier J, et al. ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11. 5-kb ORF. Nat Genet. 2000; 24: 120-5

87) Criscuolo C, Banfi S, Orio M, et al. A novel mutation in SACS gene in a family from southern Italy. Neurology. 2004; 62: 100-2

88) Grieco GS, Malandrini A, Comanducci G, et al. Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type. Neurology. 2004: 62: 103-6

89) El Euch-Fayache G, Lalani I, Amouri R, et al. Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia. Arch Neurol. 2003; 60: 982-8

90) Richter AM, Ozgul RK, Poisson VC, et al. Private SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) families from Turkey. Neurogenetics. 2004; 5: 165-70

91) Criscuolo C, Sacca F, De Michele G, et al. Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia. Mov Disord. 2005; 20: 1358-61

92) Ogawa T, Takiyama Y, Sakoe K, et al. Identification of a SACS gene missense mutation in ARSACS. Neurology. 2004; 62: 107-9

93) Shimazaki H, Takiyama Y, Sakoe K, et al. A phenotype without spasticity in sacsin-related ataxia. Neurology. 2005; 64: 2129-31

94) Yamamoto Y, Hiraoka K, Araki M, et al. Novel compound heterozygous mutations in sacsin-related ataxia. J Neurol Sci. 2005; 239: 101-4

95) Yamamoto Y, Nakamori M, Konaka K, et al. Sacsin-related ataxia caused by the novel nonsense mutation Arg4325X. J Neurol. 2006; 253: 1372-3

96) Ouyang Y, Takiyama Y, Sakoe K, et al. Sacsin-related ataxia (ARSACS): expanding the genotype upstream from the gigantic exon. Neurology. 2006; 66: 1103-4

97) Shimazaki H, Sakoe K, Niijima K, et al. An unusual case of a spasticity-lacking phenotype with a novel SACS mutation. J Neurol Sci. 2007; 255: 87-9

98) Takiyama Y. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuropathology. 2006; 26: 368-75

99) Hara K, Onodera O, Endo M, et al. Sacsin-related autosomal recessive ataxia without prominent retinal myelinated fibers in Japan. Mov Disord. 2005; 20: 380-2

100) Takado Y, Hara K, Shimohata T, et al. New mutation in the non-gigantic exon of SACS in Japanese siblings. Mov Disord. 2007; 22: 748-9

101) Hara K, Shimbo J, Nozaki H, et al. Sacsin-related ataxia with neither retinal hypermyelination nor spasticity. Mov Disord. 2007; 22: 1362-3

102) Okawa S, Sugawara M, Watanabe S, et al. A novel sacsin mutation in a Japanese woman showing clinical uniformity of autosomal recessive spastic ataxia of Charlevoix-Saguenay. J Neurol Neurosurg Psychiatry. 2006; 77: 804

103) Takiyama Y. Sacsinopathies: sacsin-related ataxia. Cerebellum. 2007; 6: 353-9

104) Chio A, Orsi L, Mortara P, et al. Early onset cerebellar ataxia with retained tendon reflexes: prevalence and gene frequency in an Italian population. Clin Genet. 1993; 43: 207-11

105) De Castro M, Cruz-Martinez A, Vilchez JJ, et al. Early onset cerebellar ataxia and preservation of tendon reflexes: clinical phenotypes associated with GAA trinucleotide repeat expanded and non-expanded genotypes. J Peripher Nerv Syst. 1999; 4: 58-62

106) Bouslam N, Bouhouche A, Benomar A, et al. A novel locus for autosomal recessive spastic ataxia on chromosome 17p. Hum Genet. 2007; 121: 413-20

107) Thiffault I, Rioux MF, Tetreault M, et al. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. Brain. 2006; 129: 2332-40

108) Bouchard JP. Recessive spastic ataxia of Charlevoix-Saguenay. In: de Jong JMBV, editor. Handbook of Clinical Neurology 16: Hereditary Neuropathies and Spinocerebellar Degenerations. Amsterdam: Elsevier Science; 1991. p. 451-9

109) Filla A, Criscuolo C, Mancini P, et al. Screening for SACS mutations in autosomal recessive spastic ataxias. Neurology. 2006; 66: A288, P05. 113 (Abstr. )

110) Tallaksen CME, Durr A. SPATAX-European network for hereditary spinocerebellar degenerative disorders. Acta Neurol Scand. 2003; 107: 432-3

111) 瀧山嘉久, 辻 省次, 佐々木秀直, 他. 痙性対麻痺全国共同研究の提案─JASPAC (Japan Spastic Paraplegia Research Consortium)─厚生労働省難病性疾患克服研究事業, 運動失調に関する調査及び病態機序に関する研究班, 平成17年度研究報告書. 2006. p. 115-8

112) 瀧山嘉久, 嶋崎晴雄, 迫江公己, 他. 本邦における遺伝性痙性対麻痺の検討─JASPAC一次アンケート調査より─厚生労働省 難病性疾患克服研究事業, 運動失調に関する調査及び病態機序に関する研究班, 平成18年度研究報告書. 2007. p. 101-3

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp